Metablue Solution
Metablue Solution is a Porto, Portugal-based medical device company founded in 2011 that develops a device for the early diagnosis of otitis, targeting clinicians in primary care and otolaryngology. No public information on products, pricing, or commercialization status is available.
- Company typePrivate
- Founded2011
- HeadquartersPorto, Portugal
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Metablue Solution does
Metablue Solution is a privately held, for-profit company founded in 2011 and headquartered in Porto, Portugal. According to its firmographic description, the company develops a disruptive medical device aimed at the early diagnosis of otitis (middle ear inflammation/infection), suggesting its target end users are clinicians in primary care, pediatrics, or otolaryngology who need faster or more accessible diagnostic tools at the point of care. The company is classified as a medical device developer rather than a pure software or services firm.
No additional details are available on the company's core products, underlying technology, proprietary features, go-to-market strategy, pricing model, or revenue mechanics. The company website (metabluesolution.com) currently displays only a loading/verification page and yields no substantive content. There are no documented funding rounds, partnerships, customer references, management team disclosures, patents, certifications, or regulatory milestones in the provided source material. As a result, the company's current commercialization stage, ownership structure, and operational scale cannot be determined from the available data.
Metablue Solution firmographics
Firmographics- Name
- Metablue Solution
- Website
- https://metabluesolution.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Short description
- Metablue Solution is a Porto, Portugal-based medical device company founded in 2011 that develops a device for the early diagnosis of otitis, targeting clinicians in primary care and otolaryngology. No public information on products, pricing, or commercialization status is available.
- Ownership category
- akta.pro rank
Where Metablue Solution is headquartered
LocationHeadquarters
- HQ city
- Porto
- HQ country
- Portugal
- HQ region
- Europe
Markets served
Metablue Solution business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations
Metablue Solution product offering
Product offeringCore offering
Metablue Solution develops a medical device designed for the early diagnosis of otitis (ear infection). The device is positioned as a disruptive diagnostic tool intended to support clinicians in identifying otitis sooner than conventional approaches.
Product overview
No product information available. The company website (http://metabluesolution.com/) displays only a loading/verification page with no accessible content.
Differentiator
Problem solved
Functional benefit
Products and services
- Otitis Early-Diagnosis Medical Device A medical device developed by Metablue Solution for the early diagnosis of otitis (ear infection). It is intended for use by clinicians and healthcare facilities seeking earlier and more reliable detection of ear infections at the point of care.
Companies that use Metablue Solution
Customer profileIdeal customer profiles1 record
Metablue Solution technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Metablue Solution partnerships and signals
Strategic signalRecent moves1 record
Metablue Solution competitors and assessment
Company assessmentDirect peers
- TytoCare: Offers a multi-modality telehealth examination device that includes an otoscope attachment for remote ear/otitis assessment. Comparable in targeting ear diagnosis, though operating in a broader telehealth-exam category.
- PhotoniCare: Maker of the TOMi Scope, an optical coherence tomography (OCT)-based ear imager for non-invasive otitis media diagnosis. Directly competes with Metablue in clinician-facing otitis diagnostic instrumentation.
- TympaHealth: Provides a smartphone-otoscope platform for ear examination and diagnosis, including otitis, used by primary-care clinicians and audiologists. Closely comparable business model and clinical use case to Metablue.
- OtoNexus Medical Technologies: Develops an ultrasound-based medical device for rapid, objective diagnosis of middle-ear effusion and otitis media. Direct head-to-head competitor with the same target indication and clinical setting as Metablue's diagnostic device.
Broad incumbents
- Heine Optotechnik: Long-established German manufacturer of high-quality medical diagnostic instruments including otoscopes used worldwide for otitis examination. Represents the incumbent standard-of-care that Metablue would seek to disrupt.
- Welch Allyn (Hillrom, now part of Baxter): Historic leader in otoscope and otitis diagnostic instrumentation, now part of Baxter following the Hillrom acquisition. Sets the incumbent benchmark in clinician ear-diagnostic devices globally.
- Grason-Stadler (GSI): Manufactures audiology and middle-ear diagnostic equipment (tympanometry, otoacoustic emissions) used by audiologists and ENT specialists for ear-disorder diagnosis, including otitis media. Comparable diagnostic adjacency though broader in scope.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
Metablue Solution financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metablue Solution leadership team
Management profileNumber of profiles
Metablue Solution funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metablue Solution M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metablue Solution
What does Metablue Solution do?
Metablue Solution develops a medical device designed for the early diagnosis of otitis (ear infection). The device is positioned as a disruptive diagnostic tool intended to support clinicians in identifying otitis sooner than conventional approaches.
When was Metablue Solution founded?
Metablue Solution was founded in 2011.
Where is Metablue Solution based?
Metablue Solution is headquartered in Porto, Portugal, in the Europe region.
Who are Metablue Solution's main competitors?
Direct peers on record are TytoCare, PhotoniCare, TympaHealth and OtoNexus Medical Technologies. Broad incumbents are Heine Optotechnik, Welch Allyn (Hillrom, now part of Baxter) and Grason-Stadler (GSI).
Does Metablue Solution have an API?
No public API is recorded for Metablue Solution.